Jackson Center, Pennsylvania--(Newsfile Corp. - July 6, 2021) - Greetings From The CEO And Staff At HALBERD CORPORATION! (OTC Pink: HALB) As we began the second quarter, the company, along with the ...
Halberd's patent position insured high potential of technical and market success. Halberd chose neurodegenerative diseases as its primary focus, since there are approximately 36 million people ...
A Major Step Towards the Elimination of Multiple Infectious Diseases and Possible Treatment for Alzheimer's Disease/PTSD/CTE Felder continued, "Our method envisions utilizing a dialysis variation in ...
JACKSON CENTER, PA / ACCESSWIRE / October 18, 2022 / Halberd Corporation (OTC PINK:HALB) has successfully eliminated various antibiotic resistant bacteria from buffer solution in-vitro through the use ...